However, despite robust expression of the RUNX1-ETO fusion transgenes in the BM upon tetracycline withdrawal in the first model and efficient excision of the floxed STOP codon in the second model, no leukaemia developed. The gene discussed is RUNX1T1; the disease is leukemia.